Tumor-Associated Macrophage Promotes Tumor Progression via STAT3 Signaling in Hepatocellular Carcinoma
Yohei Mano(National Center for Global Health and Medicine), Yoshinao Oda(Kyushu University), Ken Shirabe(Gunma University), Akinobu Taketomi(Hokkaido University), Shinichi Aishima(Saga University), Takashi Motomura(Kyushu University), Yuki Tanaka(Hokkaido University), Nobuhiro Fujita(Kyushu University), Yuichiro Kubo, Yoshihiko Maehara(Kyushu University)
Cited by 129
Related Papers
cHCC‐CCA
|Hepatology|2018|333
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244